Screening Jump-stARter Library for Leishmaniasis Drug Discovery

Status
On going
Start date
Start stage
Screening
Disease
Leishmaniasis
Research areas
Drug
Vaccine

Johnson & Johnson is sharing its Jump-stARter library with Dr. Peter Myler at Seattle Children’s Research Institute (SCRI) for screening for leishmaniasis drug discovery. Under the umbrella of the Seattle Structural Genomics Center for Infectious Disease, SCRI is partnering with the University of Washington’s Dr. Wes Van Voorhis to carry out the screening.